MedPath

Effect of Single unan8 drug on piles

Phase 2
Completed
Conditions
Health Condition 1: K648- Other hemorrhoids
Registration Number
CTRI/2019/02/017717
Lead Sponsor
luqman unsani medical college and hospital and research center vijapura
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Patients of both gender, aged >=20-60 years.

Patients with grade I and II Haemorrhoids confirmed by proctoscopy with any of the associated clinical symptoms such as rectal bleeding, constipation, mucus discharge and anal itching.

Exclusion Criteria

Patients with severe systemic disorders like DM, HTN, Severe Anemia.

Haemorrhoids with fistula in ano.Pregnant and lactating mothers.

Fissure in ano.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome measure is a response to treatment, achieving complete cessation and reduction in severity of per rectal bleeding at the end of treatment.Timepoint: befor and after treatment <br/ ><br>0 day and 21 day
Secondary Outcome Measures
NameTimeMethod
The secondary measures are the response to treatment, in reducing pile mass and proportion of patients achieving cure in other symptoms of haemorrhoids.Timepoint: befor and after treatment <br/ ><br>0 day and 21 day
© Copyright 2025. All Rights Reserved by MedPath